The PharmaEssentia
Innovation Award 2026
For therapeutic research in Hematology, Oncology, Immunology, Rare/Orphan Diseases
in Taiwan and Japan or by Taiwanese or Japanese researchers.
Prize Awards
Judges
Awards
Timeline
Three phases
Application
Easy application online in our Application Portal. Deadline in:
Tokyo Final Judging and Showcase
During Innovation Summit. In:
Check List
Eligible Business Focus Areas
Applicants must demonstrate that their core business aligns with one or more of the following focus areas:
3 categories, 5 Awards
Awards
1 x GRAND PRIZE
$100,000 USD
Priority
partnership exploration with PharmaEssentia BD/Scientific team
Featured
speaker at award ceremony + press conference
Regulatory pathway consultation
(PMDA or TFDA)
Profile in international biotech publication
2 x EXCELLENCE AWARDS
$40,000 USD each
Partnership
exploration session
Presentation at industry conference
Regulatory or
development consulting session
2 x FINALIST RECOGNITION
$10,000 USD each
Invitation
to PharmaEssentia scientific meetings
Certificate and public recognition
Expert Panel of Judges
Meet Our International Panel of Judges
Support and Documentation
Frequently Asked Questions
To be eligible for the PharmaEssentia Innovation Award, applicants must meet at least one
of the following criteria:
• The company is incorporated in Taiwan or Japan
• At least one member of the founding team holds a Taiwan or Japan passport
Additionally, applicants must meet this Funding Threshold:
Applicants must have raised less than USD $30 million in cumulative funding from investors or investment institutions. Government grants and academic funding are excluded from this calculation.
Submission of an application does not transfer any intellectual property rights to PharmaEssentia. Applicants retain full ownership of their technologies, patents, and proprietary information. PharmaEssentia makes no claims to any intellectual property disclosed during the application or evaluation process.
Ideally yes, although technologies originating from universities or research institutions that have not yet incorporated a company may apply, provided that:
• A complete patent application has been filed
• There is a documented plan to obtain full licensing rights and incorporate a company within six (6) months of the application date
Note: If selected as a winner, prize funds will be disbursed directly to the subsequently incorporated company entity.
events@tech-tokyo.org
annie_lin@pharmaessentia.com
"There's a genuinely positive patient impact that you're a part of—that's why we come to work every day."
PharmaEssentia Founder and CEO
Who created this award?
Sponsored by PharmaEssentia, organized in partnership with TECH Tokyo. Find out more:
Sponsor
About PharmaEssentia
A fully integrated, global biopharmaceutical company working to bring new, best-in-class therapies to patients with blood disorders and cancers.
Helping leading Japanese corporations access the best research, startups, and executive education from the top universities in the world
All Rights Reserved © copyright 2026 PharmaEssentia
The PharmaEssentia
Innovation Award 2026
For therapeutic research in Hematology, Oncology, Immunology, Rare/Orphan Diseases
in Taiwan and Japan or by Taiwanese or Japanese researchers.
Prize Awards
Judges
Awards
Timeline
Three phases
Application
Easy application online in our Application Portal. Deadline in:
Tokyo Final Judging and Showcase
During Innovation Summit. In:
Check List
Eligible Business Focus Areas
Applicants must demonstrate that their core business aligns with one or more of the following focus areas:
3 categories, 5 Awards
Awards
1 x GRAND PRIZE
$100,000 USD
Priority
partnership exploration with PharmaEssentia BD/Scientific team
Featured
speaker at award ceremony + press conference
Regulatory pathway consultation
(PMDA or TFDA)
Profile in international biotech publication
2 x EXCELLENCE AWARDS
$40,000 USD each
Partnership
exploration session
Presentation at industry conference
Regulatory or
development consulting session
2 x FINALIST RECOGNITION
$10,000 USD each
Invitation
to PharmaEssentia scientific meetings
Certificate and public recognition
Expert Panel of Judges
Meet Our International Panel of Judges
Support and Documentation
Frequently Asked Questions
To be eligible for the PharmaEssentia Innovation Award, applicants must meet at least one
of the following criteria:
• The company is incorporated in Taiwan or Japan
• At least one member of the founding team holds a Taiwan or Japan passport
Additionally, applicants must meet this Funding Threshold:
Applicants must have raised less than USD $30 million in cumulative funding from investors or investment institutions. Government grants and academic funding are excluded from this calculation.
Submission of an application does not transfer any intellectual property rights to PharmaEssentia. Applicants retain full ownership of their technologies, patents, and proprietary information. PharmaEssentia makes no claims to any intellectual property disclosed during the application or evaluation process.
Ideally yes, although technologies originating from universities or research institutions that have not yet incorporated a company may apply, provided that:
• A complete patent application has been filed
• There is a documented plan to obtain full licensing rights and incorporate a company within six (6) months of the application date
Note: If selected as a winner, prize funds will be disbursed directly to the subsequently incorporated company entity.
events@tech-tokyo.org
annie_lin@pharmaessentia.com
"There's a genuinely positive patient impact that you're a part of—that's why we come to work every day."
PharmaEssentia Founder and CEO
Who created this award?
Sponsored by PharmaEssentia, organized in partnership with TECH Tokyo. Find out more:
Sponsor
About PharmaEssentia
Stay up to date!
News and Updates
Award Launch and
Press Release
Finalist Judging at Innovation Symposium
Winners Announced at BioAsia Dinner
A fully integrated, global biopharmaceutical company working to bring new, best-in-class therapies to patients with blood disorders and cancers.
Helping leading Japanese corporations access the best research, startups, and executive education from the top universities in the world
All Rights Reserved © copyright 2026 PharmaEssentia